(2S)-(((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile,
Galvus,
NVP LAF237,
NVP-LAF237,
vildagliptin,
Vildagliptin,
Galvus,
274901-16-5,
Xiliarx,
Jalra,
NVP-LAF237,
Equa,
LAF-237,
NVP-LAF-237,
Vildagliptin (LAF-237),
(2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile,
CHEMBL142703,
LAF 237,
LAF237,
(2S)-1-{2-[(3-hydroxyadamantan-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile,
UNII-I6B4B2U96P,
2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-,
NVP-LAF 237,
(S)-1-[2-[(3-Hydroxyadamant-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile,
Galvus (TN),
I6B4B2U96P,
Zomelis,
Vildagliptin (JAN/USAN/INN),
(2S)-1-(2-((3-HYDROXYADAMANTAN-1-YL)AMINO)ACETYL)PYRROLIDINE-2-CARBONITRILE,
Equa (TN),
AC1OCFK2,
SCHEMBL16579,
(S)-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile,
GTPL6310,
PYR288,
Vildagliptin (NVP-LAF 237),
BDBM11695,
A10BD08,
A10BH02,
(S)-1-(2-(((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile,
CHEBI:135285,
SYOKIDBDQMKNDQ-XWTIBIIYSA-N,
2-Pyrrolidinecarbonitrile, 1-(((3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)amino)acetyl)-, (2S)-,
FD6071,
s3033,
AKOS015898120,
AC-1273,
CS-1465,
DB04876,
KS-0000024W,
NCGC00386200-01,
BC657793,
BR-49179,
HY-14291,
SC-20831,
AB1008531,
AM20090695,
SW220049-1,
D07080,
S-4169,
AB01566863_01,
(2S)-1-((3-hydroxyadamantan-1-yl)glycyl)pyrrolidine-2-carbonitrile,
(2S)-1-[N-(3-Hydroxyadamantan-1-yl)glycyl]pyrrolidine-2-carbonitrile,
(2S)-1-{[(3-hydroxyadamant-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile,
(2S)-1-{2-[(3-Hydroxyadamant-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile,
(2S)-1-{[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile,
1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2S-pyrrolidinecarbonitrile,
(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]- 2-pyrrolidinecarbonitrile,
2S)-1-[[(3-Hydroxytricyclo[3.3.1.13,7]decane-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile,
Galvu,
vildagliptin HCl,
Vildagliptin [USAN],
Vildagliptin hydrochloride,
D0L3DK,
Vidagliptin (see Vildagliptin),
NVP LAF237,
Vildagliptin [USAN:INN:BAN:JAN],
C17-H25-N3-O2,
ACN-034463,
CID6918537,
C502012,
Vildagliptin, 97%, DPP-4 inhibitor - 10MG 10mg,
D000077597,
1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine,
1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile,
(2S)-(((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile,
(2S)-1-[2-[(3-Hydroxy-tricyclo[3.3.1.13,7 ]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile,
2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-(9CI),